Global Therapeutic Radioligands Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Therapeutic Radioligands market size was valued at US$ 1020.3 million in 2022. With growing demand in downstream market, the Therapeutic Radioligands is forecast to a readjusted size of US$ 3259.9 million by 2029 with a CAGR of 18.1% during review period.
The research report highlights the growth potential of the global Therapeutic Radioligands market. Therapeutic Radioligands are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Therapeutic Radioligands. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Therapeutic Radioligands market.
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.
Key Features:
The report on Therapeutic Radioligands market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Therapeutic Radioligands market. It may include historical data, market segmentation by Type (e.g., Beta-emitting, Targeted Alpha Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Therapeutic Radioligands market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Therapeutic Radioligands market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Therapeutic Radioligands industry. This include advancements in Therapeutic Radioligands technology, Therapeutic Radioligands new entrants, Therapeutic Radioligands new investment, and other innovations that are shaping the future of Therapeutic Radioligands.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Therapeutic Radioligands market. It includes factors influencing customer ' purchasing decisions, preferences for Therapeutic Radioligands product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Therapeutic Radioligands market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Therapeutic Radioligands market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Therapeutic Radioligands market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Therapeutic Radioligands industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Therapeutic Radioligands market.
Market Segmentation:
Therapeutic Radioligands market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Therapeutic Radioligands market size was valued at US$ 1020.3 million in 2022. With growing demand in downstream market, the Therapeutic Radioligands is forecast to a readjusted size of US$ 3259.9 million by 2029 with a CAGR of 18.1% during review period.
The research report highlights the growth potential of the global Therapeutic Radioligands market. Therapeutic Radioligands are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Therapeutic Radioligands. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Therapeutic Radioligands market.
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.
Key Features:
The report on Therapeutic Radioligands market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Therapeutic Radioligands market. It may include historical data, market segmentation by Type (e.g., Beta-emitting, Targeted Alpha Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Therapeutic Radioligands market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Therapeutic Radioligands market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Therapeutic Radioligands industry. This include advancements in Therapeutic Radioligands technology, Therapeutic Radioligands new entrants, Therapeutic Radioligands new investment, and other innovations that are shaping the future of Therapeutic Radioligands.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Therapeutic Radioligands market. It includes factors influencing customer ' purchasing decisions, preferences for Therapeutic Radioligands product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Therapeutic Radioligands market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Therapeutic Radioligands market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Therapeutic Radioligands market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Therapeutic Radioligands industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Therapeutic Radioligands market.
Market Segmentation:
Therapeutic Radioligands market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Beta-emitting
- Targeted Alpha Therapy
- Solid Tumor
- Non Hodgkin Lymphoma
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Novartis
- Lantheus
- Aurobindo Pharma
- Mundipharma
- China Isotope & Radiation
- Curium Pharmaceuticals
- Gilead Sciences
- Clarity Pharmaceuticals
- Curasight
- Nordic Nanovector
- Philogen
- RadioMedix
- Telix Pharmaceuticals
- Orano Med
- Actinium Pharmaceuticals
- Y-mAbs Therapeutics
- Fusion Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Radioligands Market Size 2018-2029
2.1.2 Therapeutic Radioligands Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Radioligands Segment by Type
2.2.1 Beta-emitting
2.2.2 Targeted Alpha Therapy
2.3 Therapeutic Radioligands Market Size by Type
2.3.1 Therapeutic Radioligands Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Radioligands Segment by Application
2.4.1 Solid Tumor
2.4.2 Non Hodgkin Lymphoma
2.5 Therapeutic Radioligands Market Size by Application
2.5.1 Therapeutic Radioligands Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC RADIOLIGANDS MARKET SIZE BY PLAYER
3.1 Therapeutic Radioligands Market Size Market Share by Players
3.1.1 Global Therapeutic Radioligands Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Radioligands Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Radioligands Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RADIOLIGANDS BY REGIONS
4.1 Therapeutic Radioligands Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Radioligands Market Size Growth (2018-2023)
4.3 APAC Therapeutic Radioligands Market Size Growth (2018-2023)
4.4 Europe Therapeutic Radioligands Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Radioligands Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Radioligands Market Size by Country (2018-2023)
5.2 Americas Therapeutic Radioligands Market Size by Type (2018-2023)
5.3 Americas Therapeutic Radioligands Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Radioligands Market Size by Region (2018-2023)
6.2 APAC Therapeutic Radioligands Market Size by Type (2018-2023)
6.3 APAC Therapeutic Radioligands Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Radioligands by Country (2018-2023)
7.2 Europe Therapeutic Radioligands Market Size by Type (2018-2023)
7.3 Europe Therapeutic Radioligands Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Radioligands by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Radioligands Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Radioligands Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC RADIOLIGANDS MARKET FORECAST
10.1 Global Therapeutic Radioligands Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Radioligands Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Radioligands Forecast
10.1.3 APAC Therapeutic Radioligands Forecast
10.1.4 Europe Therapeutic Radioligands Forecast
10.1.5 Middle East & Africa Therapeutic Radioligands Forecast
10.2 Americas Therapeutic Radioligands Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Radioligands Market Forecast
10.2.2 Canada Therapeutic Radioligands Market Forecast
10.2.3 Mexico Therapeutic Radioligands Market Forecast
10.2.4 Brazil Therapeutic Radioligands Market Forecast
10.3 APAC Therapeutic Radioligands Forecast by Region (2024-2029)
10.3.1 China Therapeutic Radioligands Market Forecast
10.3.2 Japan Therapeutic Radioligands Market Forecast
10.3.3 Korea Therapeutic Radioligands Market Forecast
10.3.4 Southeast Asia Therapeutic Radioligands Market Forecast
10.3.5 India Therapeutic Radioligands Market Forecast
10.3.6 Australia Therapeutic Radioligands Market Forecast
10.4 Europe Therapeutic Radioligands Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Radioligands Market Forecast
10.4.2 France Therapeutic Radioligands Market Forecast
10.4.3 UK Therapeutic Radioligands Market Forecast
10.4.4 Italy Therapeutic Radioligands Market Forecast
10.4.5 Russia Therapeutic Radioligands Market Forecast
10.5 Middle East & Africa Therapeutic Radioligands Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Radioligands Market Forecast
10.5.2 South Africa Therapeutic Radioligands Market Forecast
10.5.3 Israel Therapeutic Radioligands Market Forecast
10.5.4 Turkey Therapeutic Radioligands Market Forecast
10.5.5 GCC Countries Therapeutic Radioligands Market Forecast
10.6 Global Therapeutic Radioligands Forecast by Type (2024-2029)
10.7 Global Therapeutic Radioligands Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Therapeutic Radioligands Product Offered
11.1.3 Bayer Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Therapeutic Radioligands Product Offered
11.2.3 Novartis Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Lantheus
11.3.1 Lantheus Company Information
11.3.2 Lantheus Therapeutic Radioligands Product Offered
11.3.3 Lantheus Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Lantheus Main Business Overview
11.3.5 Lantheus Latest Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Information
11.4.2 Aurobindo Pharma Therapeutic Radioligands Product Offered
11.4.3 Aurobindo Pharma Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aurobindo Pharma Main Business Overview
11.4.5 Aurobindo Pharma Latest Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Information
11.5.2 Mundipharma Therapeutic Radioligands Product Offered
11.5.3 Mundipharma Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mundipharma Main Business Overview
11.5.5 Mundipharma Latest Developments
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Information
11.6.2 China Isotope & Radiation Therapeutic Radioligands Product Offered
11.6.3 China Isotope & Radiation Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 China Isotope & Radiation Main Business Overview
11.6.5 China Isotope & Radiation Latest Developments
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Information
11.7.2 Curium Pharmaceuticals Therapeutic Radioligands Product Offered
11.7.3 Curium Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Curium Pharmaceuticals Main Business Overview
11.7.5 Curium Pharmaceuticals Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Therapeutic Radioligands Product Offered
11.8.3 Gilead Sciences Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Information
11.9.2 Clarity Pharmaceuticals Therapeutic Radioligands Product Offered
11.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Clarity Pharmaceuticals Main Business Overview
11.9.5 Clarity Pharmaceuticals Latest Developments
11.10 Curasight
11.10.1 Curasight Company Information
11.10.2 Curasight Therapeutic Radioligands Product Offered
11.10.3 Curasight Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Curasight Main Business Overview
11.10.5 Curasight Latest Developments
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Information
11.11.2 Nordic Nanovector Therapeutic Radioligands Product Offered
11.11.3 Nordic Nanovector Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Nordic Nanovector Main Business Overview
11.11.5 Nordic Nanovector Latest Developments
11.12 Philogen
11.12.1 Philogen Company Information
11.12.2 Philogen Therapeutic Radioligands Product Offered
11.12.3 Philogen Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Philogen Main Business Overview
11.12.5 Philogen Latest Developments
11.13 RadioMedix
11.13.1 RadioMedix Company Information
11.13.2 RadioMedix Therapeutic Radioligands Product Offered
11.13.3 RadioMedix Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 RadioMedix Main Business Overview
11.13.5 RadioMedix Latest Developments
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Information
11.14.2 Telix Pharmaceuticals Therapeutic Radioligands Product Offered
11.14.3 Telix Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Telix Pharmaceuticals Main Business Overview
11.14.5 Telix Pharmaceuticals Latest Developments
11.15 Orano Med
11.15.1 Orano Med Company Information
11.15.2 Orano Med Therapeutic Radioligands Product Offered
11.15.3 Orano Med Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Orano Med Main Business Overview
11.15.5 Orano Med Latest Developments
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Information
11.16.2 Actinium Pharmaceuticals Therapeutic Radioligands Product Offered
11.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Actinium Pharmaceuticals Main Business Overview
11.16.5 Actinium Pharmaceuticals Latest Developments
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Information
11.17.2 Y-mAbs Therapeutics Therapeutic Radioligands Product Offered
11.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Y-mAbs Therapeutics Main Business Overview
11.17.5 Y-mAbs Therapeutics Latest Developments
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Information
11.18.2 Fusion Pharmaceuticals Therapeutic Radioligands Product Offered
11.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Fusion Pharmaceuticals Main Business Overview
11.18.5 Fusion Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Radioligands Market Size 2018-2029
2.1.2 Therapeutic Radioligands Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Therapeutic Radioligands Segment by Type
2.2.1 Beta-emitting
2.2.2 Targeted Alpha Therapy
2.3 Therapeutic Radioligands Market Size by Type
2.3.1 Therapeutic Radioligands Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
2.4 Therapeutic Radioligands Segment by Application
2.4.1 Solid Tumor
2.4.2 Non Hodgkin Lymphoma
2.5 Therapeutic Radioligands Market Size by Application
2.5.1 Therapeutic Radioligands Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
3 THERAPEUTIC RADIOLIGANDS MARKET SIZE BY PLAYER
3.1 Therapeutic Radioligands Market Size Market Share by Players
3.1.1 Global Therapeutic Radioligands Revenue by Players (2018-2023)
3.1.2 Global Therapeutic Radioligands Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Radioligands Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RADIOLIGANDS BY REGIONS
4.1 Therapeutic Radioligands Market Size by Regions (2018-2023)
4.2 Americas Therapeutic Radioligands Market Size Growth (2018-2023)
4.3 APAC Therapeutic Radioligands Market Size Growth (2018-2023)
4.4 Europe Therapeutic Radioligands Market Size Growth (2018-2023)
4.5 Middle East & Africa Therapeutic Radioligands Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Therapeutic Radioligands Market Size by Country (2018-2023)
5.2 Americas Therapeutic Radioligands Market Size by Type (2018-2023)
5.3 Americas Therapeutic Radioligands Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Radioligands Market Size by Region (2018-2023)
6.2 APAC Therapeutic Radioligands Market Size by Type (2018-2023)
6.3 APAC Therapeutic Radioligands Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Therapeutic Radioligands by Country (2018-2023)
7.2 Europe Therapeutic Radioligands Market Size by Type (2018-2023)
7.3 Europe Therapeutic Radioligands Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Radioligands by Region (2018-2023)
8.2 Middle East & Africa Therapeutic Radioligands Market Size by Type (2018-2023)
8.3 Middle East & Africa Therapeutic Radioligands Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL THERAPEUTIC RADIOLIGANDS MARKET FORECAST
10.1 Global Therapeutic Radioligands Forecast by Regions (2024-2029)
10.1.1 Global Therapeutic Radioligands Forecast by Regions (2024-2029)
10.1.2 Americas Therapeutic Radioligands Forecast
10.1.3 APAC Therapeutic Radioligands Forecast
10.1.4 Europe Therapeutic Radioligands Forecast
10.1.5 Middle East & Africa Therapeutic Radioligands Forecast
10.2 Americas Therapeutic Radioligands Forecast by Country (2024-2029)
10.2.1 United States Therapeutic Radioligands Market Forecast
10.2.2 Canada Therapeutic Radioligands Market Forecast
10.2.3 Mexico Therapeutic Radioligands Market Forecast
10.2.4 Brazil Therapeutic Radioligands Market Forecast
10.3 APAC Therapeutic Radioligands Forecast by Region (2024-2029)
10.3.1 China Therapeutic Radioligands Market Forecast
10.3.2 Japan Therapeutic Radioligands Market Forecast
10.3.3 Korea Therapeutic Radioligands Market Forecast
10.3.4 Southeast Asia Therapeutic Radioligands Market Forecast
10.3.5 India Therapeutic Radioligands Market Forecast
10.3.6 Australia Therapeutic Radioligands Market Forecast
10.4 Europe Therapeutic Radioligands Forecast by Country (2024-2029)
10.4.1 Germany Therapeutic Radioligands Market Forecast
10.4.2 France Therapeutic Radioligands Market Forecast
10.4.3 UK Therapeutic Radioligands Market Forecast
10.4.4 Italy Therapeutic Radioligands Market Forecast
10.4.5 Russia Therapeutic Radioligands Market Forecast
10.5 Middle East & Africa Therapeutic Radioligands Forecast by Region (2024-2029)
10.5.1 Egypt Therapeutic Radioligands Market Forecast
10.5.2 South Africa Therapeutic Radioligands Market Forecast
10.5.3 Israel Therapeutic Radioligands Market Forecast
10.5.4 Turkey Therapeutic Radioligands Market Forecast
10.5.5 GCC Countries Therapeutic Radioligands Market Forecast
10.6 Global Therapeutic Radioligands Forecast by Type (2024-2029)
10.7 Global Therapeutic Radioligands Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Therapeutic Radioligands Product Offered
11.1.3 Bayer Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Therapeutic Radioligands Product Offered
11.2.3 Novartis Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Lantheus
11.3.1 Lantheus Company Information
11.3.2 Lantheus Therapeutic Radioligands Product Offered
11.3.3 Lantheus Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Lantheus Main Business Overview
11.3.5 Lantheus Latest Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Information
11.4.2 Aurobindo Pharma Therapeutic Radioligands Product Offered
11.4.3 Aurobindo Pharma Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aurobindo Pharma Main Business Overview
11.4.5 Aurobindo Pharma Latest Developments
11.5 Mundipharma
11.5.1 Mundipharma Company Information
11.5.2 Mundipharma Therapeutic Radioligands Product Offered
11.5.3 Mundipharma Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mundipharma Main Business Overview
11.5.5 Mundipharma Latest Developments
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Information
11.6.2 China Isotope & Radiation Therapeutic Radioligands Product Offered
11.6.3 China Isotope & Radiation Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 China Isotope & Radiation Main Business Overview
11.6.5 China Isotope & Radiation Latest Developments
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Information
11.7.2 Curium Pharmaceuticals Therapeutic Radioligands Product Offered
11.7.3 Curium Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Curium Pharmaceuticals Main Business Overview
11.7.5 Curium Pharmaceuticals Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Therapeutic Radioligands Product Offered
11.8.3 Gilead Sciences Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Information
11.9.2 Clarity Pharmaceuticals Therapeutic Radioligands Product Offered
11.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Clarity Pharmaceuticals Main Business Overview
11.9.5 Clarity Pharmaceuticals Latest Developments
11.10 Curasight
11.10.1 Curasight Company Information
11.10.2 Curasight Therapeutic Radioligands Product Offered
11.10.3 Curasight Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Curasight Main Business Overview
11.10.5 Curasight Latest Developments
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Information
11.11.2 Nordic Nanovector Therapeutic Radioligands Product Offered
11.11.3 Nordic Nanovector Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Nordic Nanovector Main Business Overview
11.11.5 Nordic Nanovector Latest Developments
11.12 Philogen
11.12.1 Philogen Company Information
11.12.2 Philogen Therapeutic Radioligands Product Offered
11.12.3 Philogen Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Philogen Main Business Overview
11.12.5 Philogen Latest Developments
11.13 RadioMedix
11.13.1 RadioMedix Company Information
11.13.2 RadioMedix Therapeutic Radioligands Product Offered
11.13.3 RadioMedix Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 RadioMedix Main Business Overview
11.13.5 RadioMedix Latest Developments
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Information
11.14.2 Telix Pharmaceuticals Therapeutic Radioligands Product Offered
11.14.3 Telix Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Telix Pharmaceuticals Main Business Overview
11.14.5 Telix Pharmaceuticals Latest Developments
11.15 Orano Med
11.15.1 Orano Med Company Information
11.15.2 Orano Med Therapeutic Radioligands Product Offered
11.15.3 Orano Med Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Orano Med Main Business Overview
11.15.5 Orano Med Latest Developments
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Information
11.16.2 Actinium Pharmaceuticals Therapeutic Radioligands Product Offered
11.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Actinium Pharmaceuticals Main Business Overview
11.16.5 Actinium Pharmaceuticals Latest Developments
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Information
11.17.2 Y-mAbs Therapeutics Therapeutic Radioligands Product Offered
11.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Y-mAbs Therapeutics Main Business Overview
11.17.5 Y-mAbs Therapeutics Latest Developments
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Information
11.18.2 Fusion Pharmaceuticals Therapeutic Radioligands Product Offered
11.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Fusion Pharmaceuticals Main Business Overview
11.18.5 Fusion Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Radioligands Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Beta-emitting
Table 3. Major Players of Targeted Alpha Therapy
Table 4. Therapeutic Radioligands Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 7. Therapeutic Radioligands Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 10. Global Therapeutic Radioligands Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Therapeutic Radioligands Revenue Market Share by Player (2018-2023)
Table 12. Therapeutic Radioligands Key Players Head office and Products Offered
Table 13. Therapeutic Radioligands Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Therapeutic Radioligands Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Therapeutic Radioligands Market Size Market Share by Regions (2018-2023)
Table 18. Global Therapeutic Radioligands Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Therapeutic Radioligands Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Therapeutic Radioligands Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Therapeutic Radioligands Market Size Market Share by Country (2018-2023)
Table 22. Americas Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 24. Americas Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 26. APAC Therapeutic Radioligands Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Table 28. APAC Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 30. APAC Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 32. Europe Therapeutic Radioligands Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Therapeutic Radioligands Market Size Market Share by Country (2018-2023)
Table 34. Europe Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 36. Europe Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Therapeutic Radioligands Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Therapeutic Radioligands
Table 45. Key Market Challenges & Risks of Therapeutic Radioligands
Table 46. Key Industry Trends of Therapeutic Radioligands
Table 47. Global Therapeutic Radioligands Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Therapeutic Radioligands Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Therapeutic Radioligands Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Therapeutic Radioligands Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Bayer Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 52. Bayer Therapeutic Radioligands Product Offered
Table 53. Bayer Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Novartis Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 57. Novartis Therapeutic Radioligands Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Lantheus Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 62. Lantheus Therapeutic Radioligands Product Offered
Table 63. Lantheus Main Business
Table 64. Lantheus Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Lantheus Latest Developments
Table 66. Aurobindo Pharma Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 67. Aurobindo Pharma Therapeutic Radioligands Product Offered
Table 68. Aurobindo Pharma Main Business
Table 69. Aurobindo Pharma Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Aurobindo Pharma Latest Developments
Table 71. Mundipharma Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 72. Mundipharma Therapeutic Radioligands Product Offered
Table 73. Mundipharma Main Business
Table 74. Mundipharma Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Mundipharma Latest Developments
Table 76. China Isotope & Radiation Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 77. China Isotope & Radiation Therapeutic Radioligands Product Offered
Table 78. China Isotope & Radiation Main Business
Table 79. China Isotope & Radiation Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. China Isotope & Radiation Latest Developments
Table 81. Curium Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 82. Curium Pharmaceuticals Therapeutic Radioligands Product Offered
Table 83. Curium Pharmaceuticals Main Business
Table 84. Curium Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Curium Pharmaceuticals Latest Developments
Table 86. Gilead Sciences Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 87. Gilead Sciences Therapeutic Radioligands Product Offered
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Gilead Sciences Latest Developments
Table 91. Clarity Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 92. Clarity Pharmaceuticals Therapeutic Radioligands Product Offered
Table 93. Clarity Pharmaceuticals Main Business
Table 94. Clarity Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Clarity Pharmaceuticals Latest Developments
Table 96. Curasight Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 97. Curasight Therapeutic Radioligands Product Offered
Table 98. Curasight Main Business
Table 99. Curasight Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Curasight Latest Developments
Table 101. Nordic Nanovector Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 102. Nordic Nanovector Therapeutic Radioligands Product Offered
Table 103. Nordic Nanovector Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Nordic Nanovector Main Business
Table 105. Nordic Nanovector Latest Developments
Table 106. Philogen Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 107. Philogen Therapeutic Radioligands Product Offered
Table 108. Philogen Main Business
Table 109. Philogen Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Philogen Latest Developments
Table 111. RadioMedix Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 112. RadioMedix Therapeutic Radioligands Product Offered
Table 113. RadioMedix Main Business
Table 114. RadioMedix Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. RadioMedix Latest Developments
Table 116. Telix Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 117. Telix Pharmaceuticals Therapeutic Radioligands Product Offered
Table 118. Telix Pharmaceuticals Main Business
Table 119. Telix Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Telix Pharmaceuticals Latest Developments
Table 121. Orano Med Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 122. Orano Med Therapeutic Radioligands Product Offered
Table 123. Orano Med Main Business
Table 124. Orano Med Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Orano Med Latest Developments
Table 126. Actinium Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 127. Actinium Pharmaceuticals Therapeutic Radioligands Product Offered
Table 128. Actinium Pharmaceuticals Main Business
Table 129. Actinium Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Actinium Pharmaceuticals Latest Developments
Table 131. Y-mAbs Therapeutics Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 132. Y-mAbs Therapeutics Therapeutic Radioligands Product Offered
Table 133. Y-mAbs Therapeutics Main Business
Table 134. Y-mAbs Therapeutics Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Y-mAbs Therapeutics Latest Developments
Table 136. Fusion Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 137. Fusion Pharmaceuticals Therapeutic Radioligands Product Offered
Table 138. Fusion Pharmaceuticals Main Business
Table 139. Fusion Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Fusion Pharmaceuticals Latest Developments
Table 1. Therapeutic Radioligands Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Beta-emitting
Table 3. Major Players of Targeted Alpha Therapy
Table 4. Therapeutic Radioligands Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 7. Therapeutic Radioligands Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 10. Global Therapeutic Radioligands Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Therapeutic Radioligands Revenue Market Share by Player (2018-2023)
Table 12. Therapeutic Radioligands Key Players Head office and Products Offered
Table 13. Therapeutic Radioligands Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Therapeutic Radioligands Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Therapeutic Radioligands Market Size Market Share by Regions (2018-2023)
Table 18. Global Therapeutic Radioligands Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Therapeutic Radioligands Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Therapeutic Radioligands Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Therapeutic Radioligands Market Size Market Share by Country (2018-2023)
Table 22. Americas Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 24. Americas Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 26. APAC Therapeutic Radioligands Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Table 28. APAC Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 30. APAC Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 32. Europe Therapeutic Radioligands Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Therapeutic Radioligands Market Size Market Share by Country (2018-2023)
Table 34. Europe Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 36. Europe Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Therapeutic Radioligands Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Therapeutic Radioligands Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Therapeutic Radioligands Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Therapeutic Radioligands
Table 45. Key Market Challenges & Risks of Therapeutic Radioligands
Table 46. Key Industry Trends of Therapeutic Radioligands
Table 47. Global Therapeutic Radioligands Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Therapeutic Radioligands Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Therapeutic Radioligands Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Therapeutic Radioligands Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Bayer Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 52. Bayer Therapeutic Radioligands Product Offered
Table 53. Bayer Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Novartis Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 57. Novartis Therapeutic Radioligands Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Lantheus Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 62. Lantheus Therapeutic Radioligands Product Offered
Table 63. Lantheus Main Business
Table 64. Lantheus Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Lantheus Latest Developments
Table 66. Aurobindo Pharma Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 67. Aurobindo Pharma Therapeutic Radioligands Product Offered
Table 68. Aurobindo Pharma Main Business
Table 69. Aurobindo Pharma Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Aurobindo Pharma Latest Developments
Table 71. Mundipharma Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 72. Mundipharma Therapeutic Radioligands Product Offered
Table 73. Mundipharma Main Business
Table 74. Mundipharma Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Mundipharma Latest Developments
Table 76. China Isotope & Radiation Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 77. China Isotope & Radiation Therapeutic Radioligands Product Offered
Table 78. China Isotope & Radiation Main Business
Table 79. China Isotope & Radiation Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. China Isotope & Radiation Latest Developments
Table 81. Curium Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 82. Curium Pharmaceuticals Therapeutic Radioligands Product Offered
Table 83. Curium Pharmaceuticals Main Business
Table 84. Curium Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Curium Pharmaceuticals Latest Developments
Table 86. Gilead Sciences Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 87. Gilead Sciences Therapeutic Radioligands Product Offered
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Gilead Sciences Latest Developments
Table 91. Clarity Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 92. Clarity Pharmaceuticals Therapeutic Radioligands Product Offered
Table 93. Clarity Pharmaceuticals Main Business
Table 94. Clarity Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Clarity Pharmaceuticals Latest Developments
Table 96. Curasight Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 97. Curasight Therapeutic Radioligands Product Offered
Table 98. Curasight Main Business
Table 99. Curasight Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Curasight Latest Developments
Table 101. Nordic Nanovector Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 102. Nordic Nanovector Therapeutic Radioligands Product Offered
Table 103. Nordic Nanovector Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Nordic Nanovector Main Business
Table 105. Nordic Nanovector Latest Developments
Table 106. Philogen Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 107. Philogen Therapeutic Radioligands Product Offered
Table 108. Philogen Main Business
Table 109. Philogen Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Philogen Latest Developments
Table 111. RadioMedix Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 112. RadioMedix Therapeutic Radioligands Product Offered
Table 113. RadioMedix Main Business
Table 114. RadioMedix Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. RadioMedix Latest Developments
Table 116. Telix Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 117. Telix Pharmaceuticals Therapeutic Radioligands Product Offered
Table 118. Telix Pharmaceuticals Main Business
Table 119. Telix Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Telix Pharmaceuticals Latest Developments
Table 121. Orano Med Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 122. Orano Med Therapeutic Radioligands Product Offered
Table 123. Orano Med Main Business
Table 124. Orano Med Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Orano Med Latest Developments
Table 126. Actinium Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 127. Actinium Pharmaceuticals Therapeutic Radioligands Product Offered
Table 128. Actinium Pharmaceuticals Main Business
Table 129. Actinium Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Actinium Pharmaceuticals Latest Developments
Table 131. Y-mAbs Therapeutics Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 132. Y-mAbs Therapeutics Therapeutic Radioligands Product Offered
Table 133. Y-mAbs Therapeutics Main Business
Table 134. Y-mAbs Therapeutics Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Y-mAbs Therapeutics Latest Developments
Table 136. Fusion Pharmaceuticals Details, Company Type, Therapeutic Radioligands Area Served and Its Competitors
Table 137. Fusion Pharmaceuticals Therapeutic Radioligands Product Offered
Table 138. Fusion Pharmaceuticals Main Business
Table 139. Fusion Pharmaceuticals Therapeutic Radioligands Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Fusion Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Therapeutic Radioligands Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Radioligands Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Radioligands Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Radioligands Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Radioligands Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Radioligands Market Size Market Share by Type in 2022
Figure 10. Therapeutic Radioligands in Solid Tumor
Figure 11. Global Therapeutic Radioligands Market: Solid Tumor (2018-2023) & ($ Millions)
Figure 12. Therapeutic Radioligands in Non Hodgkin Lymphoma
Figure 13. Global Therapeutic Radioligands Market: Non Hodgkin Lymphoma (2018-2023) & ($ Millions)
Figure 14. Global Therapeutic Radioligands Market Size Market Share by Application in 2022
Figure 15. Global Therapeutic Radioligands Revenue Market Share by Player in 2022
Figure 16. Global Therapeutic Radioligands Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 18. APAC Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 19. Europe Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 21. Americas Therapeutic Radioligands Value Market Share by Country in 2022
Figure 22. United States Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Therapeutic Radioligands Market Size Market Share by Region in 2022
Figure 27. APAC Therapeutic Radioligands Market Size Market Share by Type in 2022
Figure 28. APAC Therapeutic Radioligands Market Size Market Share by Application in 2022
Figure 29. China Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Therapeutic Radioligands Market Size Market Share by Country in 2022
Figure 36. Europe Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Figure 37. Europe Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Figure 38. Germany Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 52. APAC Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 53. Europe Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 55. United States Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 56. Canada Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 59. China Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 60. Japan Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 61. Korea Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 63. India Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 64. Australia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 65. Germany Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 66. France Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 67. UK Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 68. Italy Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 69. Russia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 70. Spain Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 73. Israel Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 76. Global Therapeutic Radioligands Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Therapeutic Radioligands Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Therapeutic Radioligands Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Therapeutic Radioligands Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Therapeutic Radioligands Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Therapeutic Radioligands Sales Market Share by Country/Region (2022)
Figure 8. Therapeutic Radioligands Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Therapeutic Radioligands Market Size Market Share by Type in 2022
Figure 10. Therapeutic Radioligands in Solid Tumor
Figure 11. Global Therapeutic Radioligands Market: Solid Tumor (2018-2023) & ($ Millions)
Figure 12. Therapeutic Radioligands in Non Hodgkin Lymphoma
Figure 13. Global Therapeutic Radioligands Market: Non Hodgkin Lymphoma (2018-2023) & ($ Millions)
Figure 14. Global Therapeutic Radioligands Market Size Market Share by Application in 2022
Figure 15. Global Therapeutic Radioligands Revenue Market Share by Player in 2022
Figure 16. Global Therapeutic Radioligands Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 18. APAC Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 19. Europe Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Therapeutic Radioligands Market Size 2018-2023 ($ Millions)
Figure 21. Americas Therapeutic Radioligands Value Market Share by Country in 2022
Figure 22. United States Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Therapeutic Radioligands Market Size Market Share by Region in 2022
Figure 27. APAC Therapeutic Radioligands Market Size Market Share by Type in 2022
Figure 28. APAC Therapeutic Radioligands Market Size Market Share by Application in 2022
Figure 29. China Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Therapeutic Radioligands Market Size Market Share by Country in 2022
Figure 36. Europe Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Figure 37. Europe Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Figure 38. Germany Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Therapeutic Radioligands Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Therapeutic Radioligands Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 52. APAC Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 53. Europe Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 55. United States Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 56. Canada Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 59. China Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 60. Japan Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 61. Korea Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 63. India Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 64. Australia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 65. Germany Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 66. France Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 67. UK Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 68. Italy Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 69. Russia Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 70. Spain Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 73. Israel Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Therapeutic Radioligands Market Size 2024-2029 ($ Millions)
Figure 76. Global Therapeutic Radioligands Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Therapeutic Radioligands Market Size Market Share Forecast by Application (2024-2029)
